T&R Biofab Co. Ltd (246710) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.002x

Based on the latest financial reports, T&R Biofab Co. Ltd (246710) has a cash flow conversion efficiency ratio of 0.002x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩17.53 Million ≈ $11.88K USD) by net assets (₩11.31 Billion ≈ $7.66 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

T&R Biofab Co. Ltd - Cash Flow Conversion Efficiency Trend (2015–2024)

This chart illustrates how T&R Biofab Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does T&R Biofab Co. Ltd carry for a breakdown of total debt and financial obligations.

T&R Biofab Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of T&R Biofab Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Korea Cable T.V Chung-Buk System Co. Ltd. KQ:066790	-0.007x
T7 Global Bhd KLSE:7228	0.023x
Pansar Bhd KLSE:8419	0.206x
Altinyag Kombinalari AS IS:ALMAD	0.013x
Helbor Empreendimentos S.A SA:HBOR3	-0.003x
Daesung Finetec Co.Ltd KQ:104040	-0.005x
Waskita Beton Precast Tbk PT JK:WSBP	0.008x
Mcleod Russel India Limited NSE:MCLEODRUSS	0.415x

Annual Cash Flow Conversion Efficiency for T&R Biofab Co. Ltd (2015–2024)

The table below shows the annual cash flow conversion efficiency of T&R Biofab Co. Ltd from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of T&R Biofab Co. Ltd.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩24.21 Billion ≈ $16.41 Million	₩-11.73 Billion ≈ $-7.95 Million	-0.485x	-117.11%
2023-12-31	₩31.20 Billion ≈ $21.14 Million	₩-6.96 Billion ≈ $-4.72 Million	-0.223x	-48.88%
2022-12-31	₩39.26 Billion ≈ $26.61 Million	₩-5.89 Billion ≈ $-3.99 Million	-0.150x	+17.34%
2021-12-31	₩41.69 Billion ≈ $28.25 Million	₩-7.56 Billion ≈ $-5.12 Million	-0.181x	+0.27%
2020-12-31	₩46.05 Billion ≈ $31.21 Million	₩-8.38 Billion ≈ $-5.68 Million	-0.182x	+12.97%
2019-12-31	₩24.76 Billion ≈ $16.78 Million	₩-5.17 Billion ≈ $-3.51 Million	-0.209x	-11.74%
2018-12-31	₩30.27 Billion ≈ $20.51 Million	₩-5.66 Billion ≈ $-3.84 Million	-0.187x	+54.45%
2017-12-31	₩9.07 Billion ≈ $6.15 Million	₩-3.72 Billion ≈ $-2.52 Million	-0.411x	-40.25%
2016-12-31	₩8.85 Billion ≈ $6.00 Million	₩-2.59 Billion ≈ $-1.76 Million	-0.293x	+0.24%
2015-12-31	₩3.58 Billion ≈ $2.42 Million	₩-1.05 Billion ≈ $-710.94K	-0.293x	--

About T&R Biofab Co. Ltd

KQ:246710 Korea Medical Devices

Market Cap

$61.19 Million

₩90.30 Billion KRW

Market Cap Rank

#21091 Global

#1319 in Korea

Share Price

₩2960.00

Change (1 day)

-2.95%

52-Week Range

₩1194.00 - ₩5530.00

All Time High

₩44150.00